Insider trading

Period: 120 months Stock: LH + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

162 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

162 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

162 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

162 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
162 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
162 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

162 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
30 Mar 2021
Schroeder Mark S EVP, President-Diagnostics Lab
Sold, plan not stated
$168.00K 667 at 251.88
11.8%
18 Feb 2021
Wilkinson Peter J SVP, Chief Accounting Officer
Sold, plan not stated
$559.59K 2,317 at 241.51
87.1%
Sold half or more
16 Feb 2021
van der Vaart Sandra D EVP, Chief Legal Officer
Sold, plan not stated 3×
$49.20K 208 at 236.55
4.5%
16 Feb 2021
Schroeder Mark S EVP, President-Diagnostics Lab
Sold, plan not stated 2×
$44.57K 188 at 237.06
4.2%
5 Feb 2021
Schroeder Mark S EVP, President-Diagnostics Lab
Sold, plan not stated
$45.85K 203 at 225.85
4.7%
5 Feb 2021
van der Vaart Sandra D EVP, Chief Legal Officer
Sold, plan not stated
$24.62K 109 at 225.85
2.5%
6 Nov 2020
Schroeder Mark S EVP, President-Diagnostics Lab
Sold, plan not stated
$126.18K 588 at 214.59
13.0%
4 Nov 2020
Kirchgraber Paul R CEO, Covance Drug Development
Sold, plan not stated
$321.20K 1,500 at 214.14
16.3%
8 Jul 2020
Sold, plan not stated
$225.06K 1,300 at 173.12
20.3%
2 Jul 2020
van der Vaart Sandra D EVP, Chief Legal Officer
Sold, plan not stated
$73.95K 435 at 170.00
9.7%
24 Jun 2020
van der Vaart Sandra D EVP, Chief Legal Officer
Sold, plan not stated 2×
$139.81K 872 at 160.33
16.3%
5 May 2020
KING DAVID P Director
Sold, plan not stated
$5.00M 31,250 at 160.00
9.1%
10 Mar 2020
Seltz Judith C EVP, CHRO
Bought
$55.62K 330 at 168.56
132%
First buy on file
28 Feb 2020
Seltz Judith C EVP, CHRO
Bought
$43.74K 250 at 174.94
opened
First buy on file
21 Feb 2020
Wilkinson Peter J SVP, Chief Accounting Officer
Sold, plan not stated
$56.33K 297 at 189.65
50.0%
Sold half or more
19 Feb 2020
Sold, plan not stated
$5.02M 26,479 at 189.76
64.3%
Sold half or more
13 Feb 2020
Sold, plan not stated
$231.28K 1,227 at 188.49
19.4%
13 Feb 2020
van der Vaart Sandra D SVP, Global General Counsel
Sold, plan not stated 2×
$39.21K 208 at 188.49
7.1%
13 Feb 2020
Schroeder Mark S EVP, President-Diagnostics Lab
Sold, plan not stated 2×
$35.44K 188 at 188.49
27.9%
10 Feb 2020
van der Vaart Sandra D SVP, Global General Counsel
Sold, plan not stated
$24.20K 133 at 181.99
5.0%
10 Feb 2020
Schroeder Mark S EVP, President-Diagnostics Lab
Sold, plan not stated
$19.65K 108 at 181.99
26.4%
28 Oct 2019
KING DAVID P President & CEO
Sold, plan not stated 3×
$4.99M 30,177 at 165.40
9.0%
23 Sep 2019
Sold, plan not stated
$446.81K 2,600 at 171.85
12.7%
4 Sep 2019
Uthgenannt Lisa J Chief Human Resources Officer
Sold, plan not stated
$415.74K 2,466 at 168.59
34.6%
30 Aug 2019
BERBERIAN LANCE SVP, Chief Information Officer
Sold, plan not stated
$1.00M 5,902 at 169.80
49.2%
5 Aug 2019
Sold, plan not stated
$81.46K 500 at 162.91
6.8%
8 Jul 2019
EISENBERG GLENN A Chief Financial Officer, EVP
Sold, plan not stated
$983.26K 5,563 at 176.75
24.6%
8 Jul 2019
van der Vaart Sandra D SVP, Global General Counsel
Sold, plan not stated
$411.47K 2,328 at 176.75
50.0%
20 Jun 2019
Sold, plan not stated
$527.00K 3,100 at 170.00
13.9%
7 Jun 2019
EISENBERG GLENN A Chief Financial Officer, EVP
Sold, plan not stated 3×
$1.67M 10,000 at 167.40
30.7%
6 May 2019
Sold, plan not stated
$81.10K 500 at 162.20
6.3%
3 May 2019
Sold, plan not stated
$615.31K 3,700 at 166.30
19.6%
2 May 2019
Uthgenannt Lisa J Chief Human Resources Officer
Sold, plan not stated
$656.00K 4,000 at 164.00
46.3%
13 Feb 2019
Sold, plan not stated
$152.59K 1,038 at 147.00
11.6%
12 Feb 2019
Sold, plan not stated
$540.41K 3,700 at 146.06
10.1%
27 Nov 2018
Sold, plan not stated
$56.75K 350 at 162.14
4.2%
5 Nov 2018
Sold, plan not stated
$604.16K 3,700 at 163.29
17.0%
6 Jun 2018
Dodson Edward T Principal Accounting Officer
Sold, plan not stated
$2.38M 13,000 at 183.35
58.8%
Sold half or more
4 Jun 2018
Uthgenannt Lisa J Chief Human Resources Officer
Sold, plan not stated
$819.45K 4,500 at 182.10
54.5%
Sold half or more
31 May 2018
BERBERIAN LANCE SVP, Chief Information Officer
Sold, plan not stated 2×
$1.00M 5,500 at 182.30
48.1%
31 May 2018
Sold, plan not stated 4×
$228.97K 1,263 at 181.29
26.5%
30 May 2018
EISENBERG GLENN A Chief Financial Officer, EVP
Sold, plan not stated 2×
$1.81M 10,000 at 181.21
39.1%
30 May 2018
Gary M. Huff CEO, LabCorp Diagnostics
Sold, plan not stated
$293.82K 1,610 at 182.50
50.0%
23 May 2018
KING DAVID P President & CEO
Sold, plan not stated 2×
$8.76M 49,966 at 175.37
18.4%
23 Apr 2018
KING DAVID P President & CEO
Sold, plan not stated 2×
$8.30M 49,967 at 166.12
18.4%
23 Mar 2018
KING DAVID P President & CEO
Sold, plan not stated 4×
$8.23M 49,967 at 164.75
21.6%
12 Feb 2018
EISENBERG GLENN A Chief Financial Officer, EVP
Sold, plan not stated 3×
$1.41M 8,400 at 167.36
37.8%
9 Feb 2018
Sold, plan not stated
$548.12K 3,300 at 166.10
15.4%
8 Feb 2018
Schechter Adam H Director
Sold, plan not stated
$213.81K 1,263 at 169.29
17.3%
30 Oct 2017
Sold, plan not stated
$149.07K 971 at 153.52
21.7%
Showing 101–150 of 162. ← Newer Page 3 of 4 Older →